Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,466 | 57,526 | 34,522 | 96,952 | 345,209 |
| Marketable Securities | 195,604 | 177,161 | 240,736 | 267,690 | 112,230 |
| Receivables | 26,379 | 20,473 | 24,790 | 28,082 | 32,439 |
| Other current assets | 12,905 | 13,774 | 20,403 | 9,352 | 10,196 |
| TOTAL | $281,281 | $278,001 | $334,971 | $415,976 | $518,826 |
| Non-Current Assets | |||||
| PPE Net | 104,855 | 117,589 | 132,103 | 141,685 | 131,547 |
| Investments And Advances | 10,785 | 10,179 | 38,871 | 200,560 | 391,907 |
| Other Non-Current Assets | 56,111 | 60,220 | 68,025 | 75,047 | 71,624 |
| TOTAL | $171,751 | $187,988 | $238,999 | $417,292 | $595,078 |
| Total Assets | $453,032 | $465,989 | $573,970 | $833,268 | $1,113,904 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 21,358 | 22,798 | 22,786 | 27,213 | 11,387 |
| Accrued Expenses | 38,390 | 38,070 | 49,703 | 46,794 | 76,111 |
| Other current liabilities | 39,609 | 34,309 | 50,567 | 48,601 | 37,889 |
| TOTAL | $118,095 | $103,194 | $130,272 | $130,434 | $130,472 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 10,452 | 115 | 148 | 1,829 | 3,333 |
| Other Non-Current Liabilities | 213,261 | 103,144 | 131,956 | 186,639 | 219,134 |
| TOTAL | $232,204 | $103,144 | $131,956 | $186,639 | $219,134 |
| Total Liabilities | $350,299 | $206,338 | $262,228 | $317,073 | $349,606 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,613 | 50,086 | 44,428 | 43,464 | 42,950 |
| Common Shares | 5 | 5 | 4 | 4 | 4 |
| Retained earnings | -1,126,027 | -932,149 | -705,047 | -441,553 | -161,232 |
| Other shareholders' equity | -687 | -741 | -4,429 | -15,401 | -2,569 |
| TOTAL | $102,733 | $259,651 | $311,742 | $516,195 | $764,298 |
| Total Liabilities And Equity | $453,032 | $465,989 | $573,970 | $833,268 | $1,113,904 |